Intestinal phase-II metabolism of quercetin in HT29 cells, 3D human intestinal tissues and in healthy volunteers: a qualitative comparison using LC-IMS-MS and LC-HRMS

References

• Ayehunie S, Landry T, Stevens Z, et al. (2018). Human primary cell-based organotypic microtissues for modeling small intestinal drug absorption. Pharm Res 35:72–89.
   PubMed Web of Science ®Google Scholar
• Bohn T, Mcdougall GJ, Alegria A, et al. (2015). Mind the gap-deficits in our knowledge of aspects impacting the bioavailability of phytochemicals and their metabolites–a position paper focusing on carotenoids and polyphenols. Mol Nutr Food Res 59:1307–23.
   PubMed Web of Science ®Google Scholar
• Bourgine J, Billaut-Laden I, Happillon M, et al. (2012). Gene expression profiling of systems involved in the metabolism and the disposition of xenobiotics: comparison between human intestinal biopsy samples and colon cell lines. Drug Metab Dispos 40:694–705.
   PubMed Web of Science ®Google Scholar
• Bruck S, Strohmeier J, Busch D, et al. (2017). Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue. Biopharm Drug Dispos 38:115–26.
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen ZJ, Jiang HD, Chen JZ. (2014). Computational studies of the regioselectivities of COMT-catalyzed meta-/para-O methylations of luteolin and quercetin. J Phys Chem B 118:470–81.
   PubMed Web of Science ®Google Scholar
• Cassidy A, Minihane AM. (2017). The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr 105:10–22.
   PubMed Web of Science ®Google Scholar
• Chalet C, Hollebrands B, Janssen HG, et al. (2018a). Identification of phase-II metabolites of flavonoids by liquid chromatography-ion-mobility spectrometry-mass spectrometry. Anal Bioanal Chem 410:471–82.
   PubMed Web of Science ®Google Scholar
• Chalet C, Rubbens J, Tack J, et al. (2018b). Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers. J Pharm Pharmacol 70:1002–8.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Dai YQ, Kong SS, et al. (2013). Luteolin is a rare substrate of human catechol-O-methyltransferase favoring a para-methylation. Mol Nutr Food Res 57:877–85.
   PubMed Web of Science ®Google Scholar
• Costa C, Tsatsakis A, Mamoulakis C, et al. (2017). Current evidence on the effect of dietary polyphenols intake on chronic diseases. Food Chem Toxicol 110:286–99.
   PubMed Web of Science ®Google Scholar
• Cummings J, Ethell BT, Jardine L, et al. (2003). Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives. Cancer Res 63:8443–50.
   PubMed Web of Science ®Google Scholar
• D'archivio M, Filesi C, Vari R, et al. (2010). Bioavailability of the polyphenols: status and controversies. Int J Mol Sci 11:1321–42.
   PubMed Web of Science ®Google Scholar
• Day AJ, Bao Y, Morgan MR, Williamson G. (2000). Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29:1234–43.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Rodriguez-Mateos A, Spencer JP, et al. (2013). Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18:1818–92.
   PubMed Web of Science ®Google Scholar
• Dias DA, Jones OA, Beale DJ, et al. (2016). Current and future perspectives on the structural identification of small molecules in biological systems. Metabolites 6:46.
   PubMed Web of Science ®Google Scholar
• Forsythe JG, Petrov AS, Walker CA, et al. (2015). Collision cross section calibrants for negative ion mode traveling wave ion mobility-mass spectrometry. Analyst 140:6853–61.
   PubMed Web of Science ®Google Scholar
• Gonzales GB. (2016). In vitro bioavailability and cellular bioactivity studies of flavonoids and flavonoid-rich plant extracts: questions, considerations and future perspectives. Proc Nutr Soc 1–7.
   PubMed Web of Science ®Google Scholar
• Hayeshi R, Hilgendorf C, Artursson P, et al. (2008). Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur J Pharm Sci 35:383–96.
   PubMed Web of Science ®Google Scholar
• Hopfgartner G, Tonoli D, Varesio E. (2012). High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Anal Bioanal Chem 402:2587–96.
   PubMed Web of Science ®Google Scholar
• Hubatsch I, Ragnarsson EG, Artursson P. (2007). Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc 2:2111–19.
   PubMed Web of Science ®Google Scholar
• Jaganath IB, Mullen W, Edwards CA, Crozier A. (2006). The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radic Res 40:1035–46.
   PubMed Web of Science ®Google Scholar
• Jiang W, Hu M. (2012). Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways. RSC Adv 2:7948–63.
   PubMed Web of Science ®Google Scholar
• Kay CD. (2015). Rethinking paradigms for studying mechanisms of action of plant bioactives. Nutr Bull 40:335–9.
   PubMed Web of Science ®Google Scholar
• Lapthorn C, Pullen F, Chowdhry BZ. (2013). Ion mobility spectrometry-mass spectrometry (IMS-MS) of small molecules: separating and assigning structures to ions. Mass Spectrom Rev 32:43–71.
   PubMed Web of Science ®Google Scholar
• Lee J, Ebeler SE, Zweigenbaum JA, Mitchell AE. (2012). UHPLC-(ESI)QTOF MS/MS profiling of quercetin metabolites in human plasma postconsumption of applesauce enriched with apple peel and onion. J Agric Food Chem 60:8510–20.
   PubMed Web of Science ®Google Scholar
• Li X, Zhao Y, Hou S, et al. (2014). Identification of the bioactive components of orally administered Lithocarpus polystachyus rehd and their metabolites in rats by liquid chromatography coupled to ltq orbitrap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 962:37–43.
   PubMed Web of Science ®Google Scholar
• Martínez-Maqueda D, Miralles B, Recio I. (2015). HT29 Cell Line. In K. Verhoeckx et al. eds. The impact of food bio-actives on gut health. Springer, Cham: 113–124.
   Google Scholar
• Maschmeyer I, Lorenz AK, Schimek K, et al. (2015). A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 15:2688–99.
   PubMed Web of Science ®Google Scholar
• Mullen W, Edwards CA, Crozier A. (2006). Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br. J. Nutr 96:107–16.
   PubMed Web of Science ®Google Scholar
• Ölander M, Wiśniewski JR, Matsson P, et al. (2016). The proteome of filter-grown caco-2 cells with a focus on proteins involved in drug disposition. J Pharm Sci 105:817–27.
   PubMed Web of Science ®Google Scholar
• Orrego-Lagaron N, Vallverdu-Queralt A, Martinez-Huelamo M, et al. (2016). Metabolic profile of naringenin in the stomach and colon using liquid chromatography/electrospray ionization linear ion trap quadrupole-Orbitrap-mass spectrometry (LC-ESI-LTQ-Orbitrap-MS) and LC-ESI-MS/MS. J Pharm Biomed Anal 120:38–45.
   PubMed Web of Science ®Google Scholar
• Ottaviani JI, Fong RY, Borges G, et al. (2018). Use of LC-MS for the quantitative analysis of (poly)phenol metabolites does not necessarily yield accurate results: implications for assessing existing data and conducting future research. Free Radic Biol Med 124:97–103.
   PubMed Web of Science ®Google Scholar
• Paglia G, Williams JP, Menikarachchi L, et al. (2014). Ion mobility derived collision cross sections to support metabolomics applications. Anal Chem 86:3985–93.
   PubMed Web of Science ®Google Scholar
• Santos-Buelga C, González-Manzano S, Duenas M, González-Paramás A. 2012. Analysis and Characterisation of Flavonoid Phase II Metabolites. In V. Cheynier, P. Sarni-Manchado & S. Quideau eds. Recent advances in polyphenol research. Oxford: John Wiley & Sons, Ltd: 249–286.
   Google Scholar
• Shimizu A, Ohe T, Chiba M. (2012). A novel method for the determination of the site of glucuronidation by ion mobility spectrometry-mass spectrometry. Drug Metab Dispos 40:1456–9.
   PubMed Web of Science ®Google Scholar
• Siissalo S, Laine L, Tolonen A, et al. (2010). Caco-2 cell monolayers as a tool to study simultaneous phase II metabolism and metabolite efflux of indomethacin, paracetamol and 1-naphthol. Int J Pharm 383:24–9.
   PubMed Web of Science ®Google Scholar
• Vaessen SF, Van Lipzig MM, Pieters RH, et al. (2017). Regional expression levels of drug transporters and metabolizing enzymes along the pig and human intestinal tract and comparison with caco-2 cells. Drug Metab Dispos 45:353–60.
   PubMed Web of Science ®Google Scholar
• Van Der Woude H, Boersma MG, Vervoort J, Rietjens IM. (2004). Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem Res Toxicol 17:1520–30.
   PubMed Web of Science ®Google Scholar
• Van Zanden JJ, Van Der Woude H, Vaessen J, et al. (2007). The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 74:345–51.
   PubMed Web of Science ®Google Scholar
• Vrobel I, Friedecky D, Faber E, et al. (2017). Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis. Eur J Pharm Sci 104:335–43.
   PubMed Web of Science ®Google Scholar
• Williamson G, Aeberli I, Miguet L, et al. (2007). Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metab Dispos 35:1262–8.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Knaze V, Rothwell JA, et al. (2016). Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr 55:1359–75.
   PubMed Web of Science ®Google Scholar
• Zheng L, Zhu L, Zhao M, et al. (2016). In vivo exposure of kaempferol is driven by phase ii metabolic enzymes and efflux transporters. AAPS J 18:1289–99.
   PubMed Web of Science ®Google Scholar